scholarly article | Q13442814 |
P50 | author | Ingrid Hedenfalk | Q55816354 |
Véronique Ouellet | Q76400070 | ||
P2093 | author name string | Matthew G Annis | |
Peter M Siegel | |||
Hans-Georg Simon | |||
Atilla Omeroglu | |||
Siker Kimbung | |||
Sébastien Tabariès | |||
Logan A Walsh | |||
Alexander McNulty | |||
Brennan Lavoie | |||
Maude Vinette | |||
Mireille Dessureault | |||
Yasmina Hachem | |||
P2860 | cites work | Genome engineering using the CRISPR-Cas9 system | Q22122027 |
Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells | Q24302552 | ||
MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling | Q24304423 | ||
Afadin: A novel actin filament-binding protein with one PDZ domain localized at cadherin-based cell-to-cell adherens junction | Q24678766 | ||
Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins | Q24682136 | ||
Identification of brain- and bone-specific breast cancer metastasis genes | Q39900757 | ||
Phosphorylation of claudin-4 is required for tight junction formation in a human keratinocyte cell line | Q39940922 | ||
AF6/s-afadin is a dual residency protein and localizes to a novel subnuclear compartment. | Q40225192 | ||
Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas | Q40343656 | ||
The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. | Q40360748 | ||
Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma | Q42472265 | ||
Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia | Q42476044 | ||
Involvement of the nectin-afadin complex in PDGF-induced cell survival | Q42812519 | ||
Localization of nectin-free afadin at the leading edge and its involvement in directional cell movement induced by platelet-derived growth factor | Q42832490 | ||
Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis | Q43088240 | ||
The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue | Q43529684 | ||
CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231. | Q47380086 | ||
Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. | Q53321282 | ||
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. | Q55042166 | ||
CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway | Q57813171 | ||
Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis | Q62091628 | ||
The cytoplasmic tails of claudins can influence tight junction barrier properties through effects on protein stability | Q80561465 | ||
Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer | Q81520359 | ||
Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity | Q95796280 | ||
Concomitant binding of Afadin to LGN and F-actin directs planar spindle orientation | Q27703589 | ||
Osteoactivin promotes breast cancer metastasis to bone | Q28254151 | ||
SUMOylation of claudin-2 | Q28269524 | ||
Enigma prevents Cbl-c-mediated ubiquitination and degradation of RETMEN2A | Q28539113 | ||
Genes that mediate breast cancer metastasis to lung | Q29547479 | ||
Epithelial barrier assembly requires coordinated activity of multiple domains of the tight junction protein ZO-1 | Q30009921 | ||
Involvement of the interaction of afadin with ZO-1 in the formation of tight junctions in Madin-Darby canine kidney cells | Q30157022 | ||
LMP4 regulates Tbx5 protein subcellular localization and activity | Q30480448 | ||
LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis | Q30847518 | ||
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression | Q33664419 | ||
Coordinated nuclear and synaptic shuttling of afadin promotes spine plasticity and histone modifications | Q33675888 | ||
Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer | Q33890758 | ||
Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice | Q34360157 | ||
Structure and function of claudins. | Q34585322 | ||
Loss of AF-6/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancer | Q35440276 | ||
Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways. | Q36202958 | ||
Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes | Q36210944 | ||
Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner | Q36435764 | ||
Phosphorylation of claudin-2 on serine 208 promotes membrane retention and reduces trafficking to lysosomes | Q36452928 | ||
The tumor cell-host organ interface in the early onset of metastatic organ colonisation | Q37023821 | ||
Targeting tight junction proteins-significance for drug development | Q37085094 | ||
Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers | Q37392200 | ||
Tight junctions in cancer metastasis | Q37825185 | ||
Afadin/AF-6 and canoe: roles in cell adhesion and beyond | Q38088490 | ||
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences | Q38394007 | ||
A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion | Q38715630 | ||
Loss of polarity protein AF6 promotes pancreatic cancer metastasis by inducing Snail expression | Q38870713 | ||
The role of claudins in cancer metastasis | Q38927656 | ||
Nuclear distribution of claudin-2 increases cell proliferation in human lung adenocarcinoma cells | Q38987317 | ||
Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer | Q39039014 | ||
Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth. | Q39561464 | ||
Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation. | Q39579734 | ||
Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes. | Q39631925 | ||
Participation of the second extracellular loop of claudin-5 in paracellular tightening against ions, small and large molecules | Q39723716 | ||
P433 | issue | 3-4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lung metastasis | Q1877473 |
liver metastasis | Q18967325 | ||
Claudin-2 | Q24720260 | ||
cancer metastasis | Q120912394 | ||
P304 | page(s) | 180-193 | |
P577 | publication date | 2019-01-28 | |
P1433 | published in | Genes & Development | Q1524533 |
P1476 | title | Afadin cooperates with Claudin-2 to promote breast cancer metastasis | |
P478 | volume | 33 |
Search more.